Cambridge-based biotech company Moderna, Inc. has made a name for itself in the field of messenger RNA (mRNA) therapeutics and vaccines. The company's products target a range of medical issues including infectious diseases, rare diseases, cardiovascular diseases, and immuno-oncology. Moderna's portfolio includes respiratory vaccines for ailments such as COVID-19, flu, respiratory syncytial virus, and endemics like HCoV, as well as latent vaccines for herpes simplex virus and other ailments. Additionally, the company offers systemic secreted and cell surface therapeutics, cancer vaccines, and intratumoral immuno-oncology products. Moderna has strong ties to other major pharmaceutical companies including AstraZeneca, Merck, and Vertex Pharmaceuticals. Founded in 2010 as Moderna Therapeutics, Inc., the company later changed its name to Moderna, Inc. in August 2018.